Conduct of Research Activities. Each Party shall diligently perform or cause to be performed its Research Activities in good scientific manner and in compliance in all material respects with all Applicable Laws, including good laboratory practice and good clinical practices to the extent applicable.
Conduct of Research Activities. During the Research Term and subject to the JSC's and JRC's review and, as applicable, approval of each Research Plan, the Parties will use Commercially Reasonable Efforts to perform (themselves or through their Affiliates or subject to Section 4.2, permitted subcontractors) the Research Plan Activities in accordance with the applicable Research Plan until the Development Candidate Selection Date for a Research Compound for such Research Target. NVS will have the option, in its sole discretion, to extend the Research Term for [***] period (the original Research Term plus such [***] period, the "Extended Research Term"). In the event that NVS desires to exercise such option, it shall provide Pliant with written notice to that effect at least [***] days prior to the end of the Research Term. If a Party anticipates that material Research Plan Activities under the applicable Research Plan will not have been completed by the end of the Extended Research Term, such Party may so notify the other Party at least [***] days prior to the end of the Extended Research Term, in which case the Parties will discuss in good faith the process for completing such Research Plan Activities and the extension of the Research Term for a further [***] period following the Extended Research Term (a "Second Extension"). For clarity, neither Party will be obligated to agree to a Second Extension, and if the Parties do not agree in writing to a Second Extension prior to the date upon which the Extended Research Term would otherwise expire, the Research Term shall expire upon the date of expiration of the Extended Research Term. In performing its respective Research Plan Activities, each Party: (a) will conduct such activities in a good scientific manner, in compliance with all Applicable Law in all material respects, including, where applicable, cGMP, cGLP, cGCP, and current international regulatory standards; and (b) will not employ or use any Debarred Person. [***]
Conduct of Research Activities. During the Research Term and subject to the JSC’s and JRDC’s review and, as applicable, approval of each Research Plan, the Parties will use Commercially Reasonable Efforts to perform (themselves or through their Affiliates or subject to Section 3.3(b) permitted subcontractors) the Research Plan Activities in accordance with the applicable Research Plan and the timelines set forth therein to achieve selection of a Research Compound with respect to a Target as a Development Candidate. On a Target-by-Target basis, the Research Program will begin on [***], and end upon the earlier of (i) the date of selection by Novartis of a DC with respect to such Target pursuant to Section 2.4 (the “Development Candidate Selection Date”), and (ii) [***] after the Effective Date (the “Calendar Term”), which period may be extended by mutual written agreement of the Parties (the “Research Term”). In performing its respective Research Plan Activities, each Party: (a) will conduct such activities in a good scientific manner, in compliance with all applicable Law in all material respects, including, where applicable, cGMP, cGLP, cGCP, and current international regulatory standards; and (b) will not employ or use any Debarred Person.
Conduct of Research Activities a) Each of GSK and TIGET will use their respective Commercially Reasonable Efforts to conduct the activities (the “Research”), as agreed between the Parties, for the purpose of achieving the specific research goals set forth in Exhibit A, attached hereto and incorporated herein by reference (the “Research Goals”). TIGET will propose to GSK those specific Research activities to be conducted by TIGET and/or by GSK with respect to the Research and will in good faith consider the reasonable comments and input of GSK with respect to the design and conduct of such activities. TIGET agrees to provide and will provide to GSK within a reasonable time access to the TIGET Methodologies. TIGET therefore hereby grants to GSK a non-exclusive, fully paid-up, royalty-free, sub-licenseable right and license under the TIGET Methodologies (provided however that with respect to such TIGET Methodologies that are not owned exclusively by TIGET, such right and license is granted to the extent TIGET has the legal right to grant such license). Each Party also grants to the other Party a non-exclusive, fully paid-up, royalty-free, worldwide, sublicenseable right and license for any and all purposes under its interest (under the following Section 3) in the methods, processes and tests arising from the conduct of the Research.
b) The Parties may, from time to time, determine that it may be necessary to provide materials from one Party to the other for use in the conduct of the Research. For the avoidance of doubt, the terms of section 2.8 (Material Transfer) of the Collaboration Agreement shall be deemed to apply to any transfer of materials from one Party to the other Party hereunder.
c) All activities conducted by either GSK or TIGET pursuant to this Third Side Letter Agreement shall be deemed to have been conducted within the scope of a Collaboration Program under the Collaboration Agreement.
Conduct of Research Activities. Research Site shall perform the Research Activities and use reasonable efforts to achieve the milestones, timeline and deliverables set forth in the relevant Statement of Work. The Statement of Work may only be changed or amended by agreement in writing signed by both Parties. Research Site undertakes to cooperate, perform and fulfil, promptly and on time, all of its obligations (including conducting the Research Activities) under this Agreement in accordance with applicable professional standards and best academic practices (including the ICH-GCP) within the field and in compliance with applicable laws, in a manner of good faith. Research Site shall provide all necessary qualified personnel, individuals, equipment, materials, and facilities to accomplish the Research Activities. Research Site shall provide regular training to personnel involved with the Research Activities, in accordance with the Research Protocol, and shall maintain training records for personnel participating in the Research Activities. Before any work involving Research Subjects is performed under this Agreement, Research Site will obtain approval for the Research Activities from the institutional review board or similar body necessary for Research Site to perform the Research Activities. Research Site will obtain and maintain all regulatory and ethical licenses, filings, consents, permits, approvals and other actions required by applicable law, rules, regulations and Research Site’s policies to perform the Research Activities or all of the persons who perform Research Activities on its behalf. Research Site has obtained, and shall obtain, appropriate consent from all Research Subjects necessary for Research Site to perform its obligations and grant the rights set forth in this Agreement, as needed to comply with applicable law. Research Site shall (i) supervise all individuals performing activities under this Agreement, and (ii) cause all individuals performing Research Activities to comply with the terms of this Agreement.
Conduct of Research Activities. . The Parties shall: (a) perform or cause to be performed the Research Activities in good scientific manner in accordance with generally accepted professional standards of workmanship and effort at a quality comparable to research performed at major public and private research universities within the United States and in compliance with Applicable Laws; (b) pursue the objectives of the Research Plan efficiently and expeditiously by allocating sufficient time, effort, equipment and skilled personnel to complete such activities diligently and promptly; (c) adhere to the foundational principles of team science upon which KPMP is built; (d) include in intellectual property claims, all investigators who contribute to said intellectual property by using KPMP resource; (e) adhere to the same policies and guidelines as all KPMP members; (f) adhere to all NIH and KPMP rules and guidelines governing access to data and resources, transparency, and data sharing to the public domain and; (g) share results from their studies for inclusion in the KPMP knowledge network and to work with KMAP to establish resources such that incoming data is accessible and understandable. Use of KPMP Resources (including Biosamples and associated De-identified Participant Data. Institution acknowledges that it has adequate facilities and relevant permissions and ethical approvals for the collection of clinical samples. Institution further confirms that (a) the use of data, biosamples or any other KPMP resources for the Research Activities and Research Plan and (b) sharing and ownership of the Data and associated De-identified Patient Data (and other Project Results and Project Interpretation as specified in Section 4 by/with a commercial entity Company is in accordance with Applicable Laws and the relevant Informed Consents. Use of the KPMP Resources is limited to the Company Investigator and researchers under the direct supervision of the Company Investigator and are held to the provisions and restrictions of this Agreement. No further distribution of KPMP Resources to third parties will be allowed without the prior written approval of Institution who is bound by all established NIH/NIDDK data sharing policies. Company shall not use or disclose KPMP Resources in any manner that is not specifically authorized by this Agreement or would constitute a violation of federal law, specifically HIPAA or any other applicable privacy law. Company must obtain specific authorization in the form of an...
Conduct of Research Activities. Following approval of each Research Plan as set forth in Section 3.2, with respect to each Research Plan, MeiraGTx will use Commercially Reasonable Efforts to perform (itself or through its Affiliates or subject to Section 4.4, permitted subcontractors) the Research Plan Activities associated with such Research Plan in accordance with the applicable Research Plan (including the timelines set forth therein) for the duration of the Research Plan Term. In performing its respective Research Plan Activities, MeiraGTx: (a) will conduct such activities in a good scientific manner and in compliance with all Applicable Laws in all material respects, including, where applicable, cGMP, cGLP, cGCP, good pharmacovigilance practices and current international regulatory standards; (b) will not employ or use any Debarred Person; and (c) will not use any MeiraGTx [***] Technology during the course of performing Research Plan Activities or incorporate any MeiraGTx [***] Technology into any Research IRD Product [***].
Conduct of Research Activities. Sponsor and both Institutions shall: (a) perform or cause to be performed the Research Activities in good scientific manner and in compliance with Applicable Laws, (b) pursue the objectives of the Research Plan efficiently and expeditiously by allocating sufficient time, effort, equipment and skilled personnel to complete such activities diligently and promptly, and (c) if the Research Activities involve the use of animals, the Research Activities shall be conducted in accordance with Company’s Global Policy on Bioethics, which can be found at: which can be found by clicking the “Resources” tab on the same may be amended from time to time. This policy defines the principles, behaviours and ethical standards governing Company’s research and development activities worldwide.
Conduct of Research Activities. Subject to the JRC’s review and approval of any amendments to the Research Plan, the Parties will use [***] to perform (or subject to Section 2.7 (Subcontractors), have their permitted subcontractors perform) the Research Plan Activities in accordance with the Research Plan. In performing its respective Research Plan Activities, each Party: (a) will conduct such activities in a good scientific manner, in compliance with all Applicable Law in all material respects, including, where applicable, cGLP and current international regulatory standards; and (b) will not employ or use any Debarred Person.
Conduct of Research Activities. Each Party will conduct and use Commercially Reasonable Efforts to complete the Research Activities allocated to it under the Research Plan. Each Party will, and will require its Affiliates and subcontractors to, perform its obligations under the Research Plan in compliance with Applicable Law.
